Seegene is a leading developer of multiplex molecular assays and automated solutions for US clinical labs
What You Need to Know About SARS-CoV-2 Variant Tracking - Delta, Omicron, and others
Tracking, researching, and responding to variants is now an important part of our global health response to the COVID-19 pandemic. Understanding the implications of these different mutations (and their combined impact) is a key part of this strategy.
Seegene's response to the Omicron Variant
Introducing Seegene Mobile Station
High Multiplex RT-PCR Testing for COVID-19 and Other Pathogens
Seegene Allplex™ and Novaplex™ Assays
Allplex™ 2019-nCoV (SARS-CoV-2) Assay
Novaplex™ SARS-CoV-2 / FluA / FluB / RSV Assay*
Novaplex™ SARS-CoV-2 Variants Assays*
* Research Use Only
COVID-19: Find the solution that's right for you...
Blog & Press Releases
Don’t Let Your Omicron Genes Drop Out: The Value of Variant-Specific Assays in Detecting New SARS-CoV-2 Strains
The recently reported Omicron variant of SARS-CoV-2 has a 69-70del mutation in the S-gene (which codes for the spike protein). This implies that the S-gene
Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube
The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron and its Stealth version. Published on: PR Newswire Seegene Inc.